Praxis Precision Medicine... (PRAX)
NASDAQ: PRAX
· Real-Time Price · USD
37.38
-1.04 (-2.71%)
At close: May 13, 2025, 3:59 PM
37.49
0.29%
After-hours: May 13, 2025, 05:52 PM EDT
-2.71% (1D)
| Bid | 36.48 |
| Market Cap | 761.39M |
| Revenue (ttm) | 8.12M |
| Net Income (ttm) | -212.56M |
| EPS (ttm) | -10.66 |
| PE Ratio (ttm) | -3.51 |
| Forward PE | -3.23 |
| Analyst | Buy |
| Ask | 37.5 |
| Volume | 215,967 |
| Avg. Volume (20D) | 555,842 |
| Open | 38.36 |
| Previous Close | 38.42 |
| Day's Range | 36.74 - 38.36 |
| 52-Week Range | 26.70 - 91.83 |
| Beta | 2.67 |
About PRAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PRAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PRAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-13.08%
Praxis Precision Mediciines shares are trading low...
Unlock content with
Pro Subscription
2 months ago
-40.64%
Praxis Precision Medicines shares are trading lower after the company reported a Q4 EPS miss.
2 months ago · seekingalpha.com
Praxis: A High-Risk, High-Reward Epilepsy Play Post Ulixacaltamide (Rating Upgrade)Ulixacaltamide's Phase 3 study was recommended to stop for futility, significantly lowering its chances of success in essential tremor. Investor focus shifts to the epilepsy pipeline, led by vormatrig...
